This Article Full Text Full Text (PDF) Supplementary Data All Versions of this Article: 0008-5472.CAN-08-1721v1 69/10/4301    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Hong, C. Articles by Park, S.-H. PubMed PubMed Citation Articles by Hong, C. Articles by Park, S.-H.

Regulation of Secondary Antigen-Specific CD8⁺ T-Cell Responses by Natural Killer T Cells

¹ School of Life Sciences and Biotechnology, Korea University; ² Rheumatism Research Center, The Catholic University of Korea; and ³ Department of Bioscience and Biotechnology, Sejong University, Seoul, Korea

Requests for reprints: Se-Ho Park, School of Life Sciences and Biotechnology, Korea University, Sungbukku Anamdong, Seoul 136-701, Korea. Phone: 82-2-3290-3160; Fax: 82-2-927-9028; E-mail: sehopark{at}korea.ac.kr.

Key Words: Adaptive immune response • CD1d • NKT cells • Secondary immune response

The physiologic function of natural killer T (NKT) cells in adaptive immunity remains largely unknown because most studies have used NKT cell agonists. In the present study, the role of NKT cells during the secondary effector phase was investigated separately from the primary immunization phase via adoptive transfer of differentiated effector T cells into naive recipients. We found that secondary antitumor CD8⁺ T-cell responses were optimal when NKT cells were present. Tumor-specific CD8⁺ effector T cells responded less strongly to tumor cell challenge in NKT cell–deficient recipients than in recipients with intact NKT cells. NKT cell–mediated enhancement of the secondary antitumor CD8⁺ T-cell response was concurrent with increased number and activity of tumor-specific CD8⁺ T cells. These findings provide the first demonstration of a direct role for NKT cells in the regulation of antigen-specific secondary T-cell responses without the use of exogenous NKT cell agonists such as -galactosylceramide (-GalCer). Furthermore, forced activation of NKT cells with -GalCer during the secondary immune response in suboptimally immunized animals enhanced otherwise poor tumor rejection responses. Taken together, our findings strongly emphasize the importance of NKT cells in secondary CD8⁺ T-cell immune responses. [Cancer Res 2009;69(10):4301–8]